Craig Stuart Millian - Net Worth and Insider Trading
Craig Stuart Millian Net Worth
The estimated net worth of Craig Stuart Millian is at least $15,876 dollars as of 2024-11-29. Craig Stuart Millian is the COO of Corbus Pharmaceuticals Holdings Inc and owns about 900 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) stock worth over $15,876. Details can be seen in Craig Stuart Millian's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Craig Stuart Millian has not made any transactions after 2022-08-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Craig Stuart Millian
Craig Stuart Millian Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Craig Stuart Millian owns 1 companies in total, including Corbus Pharmaceuticals Holdings Inc (CRBP) .
Click here to see the complete history of Craig Stuart Millian’s form 4 insider trades.
Insider Ownership Summary of Craig Stuart Millian
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRBP | Corbus Pharmaceuticals Holdings Inc | 2022-08-10 | Chief Commercial Officer |
Craig Stuart Millian Latest Holdings Summary
Craig Stuart Millian currently owns a total of 1 stock. Craig Stuart Millian owns 900 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) as of August 10, 2022, with a value of $15,876.
Latest Holdings of Craig Stuart Millian
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRBP | Corbus Pharmaceuticals Holdings Inc | 2022-08-10 | 900 | 17.64 | 15,876 |
Holding Weightings of Craig Stuart Millian
Craig Stuart Millian Form 4 Trading Tracker
According to the SEC Form 4 filings, Craig Stuart Millian has made a total of 3 transactions in Corbus Pharmaceuticals Holdings Inc (CRBP) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Corbus Pharmaceuticals Holdings Inc is the acquisition of 167 shares on August 10, 2022, which cost Craig Stuart Millian around $1,250.
Insider Trading History of Craig Stuart Millian
- 1
Craig Stuart Millian Trading Performance
GuruFocus tracks the stock performance after each of Craig Stuart Millian's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Craig Stuart Millian is -1.27%. GuruFocus also compares Craig Stuart Millian's trading performance to market benchmark return within the same time period. The performance of stocks bought by Craig Stuart Millian within 3 months outperforms 2 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Craig Stuart Millian's insider trading performs compared to the benchmark.
Performance of Craig Stuart Millian
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.39 | | | | | |
| Relative Return to S&P 500(%) | 0.29 | | | | | |
Craig Stuart Millian Ownership Network
Craig Stuart Millian Owned Company Details
What does Corbus Pharmaceuticals Holdings Inc do?
Who are the key executives at Corbus Pharmaceuticals Holdings Inc?
Craig Stuart Millian is the Chief Commercial Officer of Corbus Pharmaceuticals Holdings Inc. Other key executives at Corbus Pharmaceuticals Holdings Inc include Chief Financial Officer Sean F. Moran , director & Chief Executive Officer Yuval Cohen , and Chief Scientific Officer Rachael Louise Brake .
Corbus Pharmaceuticals Holdings Inc (CRBP) Insider Trades Summary
Over the past 18 months, Craig Stuart Millian made no insider transaction in Corbus Pharmaceuticals Holdings Inc (CRBP). Other recent insider transactions involving Corbus Pharmaceuticals Holdings Inc (CRBP) include a net purchase of 1,032,632 shares made by Cormorant Global Healthcare Master Fund, Lp , a net purchase of 900,000 shares made by Cormorant Asset Management, Lp , and a net sale of 63,358 shares made by Yuval Cohen .
In summary, during the past 3 months, insiders sold 0 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) in total and bought 350,000 shares, with a net purchase of 350,000 shares. During the past 18 months, 81,401 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) were sold and 1,932,632 shares were bought by its insiders, resulting in a net purchase of 1,851,231 shares.
Corbus Pharmaceuticals Holdings Inc (CRBP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Corbus Pharmaceuticals Holdings Inc Insider Transactions
Craig Stuart Millian Mailing Address
Above is the net worth, insider trading, and ownership report for Craig Stuart Millian. You might contact Craig Stuart Millian via mailing address: C/o Corbus Pharmaceuticals Holdings, Inc, 100 River Ridge Drive, Norwood Ma 02062.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
